Swedish Orphan (Germany) Market Value
| B6E Stock | EUR 26.48 0.04 0.15% |
| Symbol | Swedish |
Swedish Orphan 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Swedish Orphan's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Swedish Orphan.
| 11/22/2024 |
| 12/22/2024 |
If you would invest 0.00 in Swedish Orphan on November 22, 2024 and sell it all today you would earn a total of 0.00 from holding Swedish Orphan Biovitrum or generate 0.0% return on investment in Swedish Orphan over 30 days. Swedish Orphan is related to or competes with Zoetis, Takeda Pharmaceutical, Eisai, Shionogi, Catalent, Teva Pharmaceutical, and Ipsen SA. Swedish Orphan Biovitrum AB , an integrated biotechnology company, researches, develops, manufactures, and sells pharmac... More
Swedish Orphan Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Swedish Orphan's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Swedish Orphan Biovitrum upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 18.15 | |||
| Value At Risk | (3.35) | |||
| Potential Upside | 1.99 |
Swedish Orphan Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Swedish Orphan's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Swedish Orphan's standard deviation. In reality, there are many statistical measures that can use Swedish Orphan historical prices to predict the future Swedish Orphan's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | (0.16) | |||
| Treynor Ratio | 0.3495 |
Swedish Orphan Biovitrum Backtested Returns
Swedish Orphan Biovitrum owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0307, which indicates the firm had a -0.0307% return per unit of risk over the last 3 months. Swedish Orphan Biovitrum exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Swedish Orphan's Risk Adjusted Performance of (0.02), coefficient of variation of (2,659), and Variance of 5.31 to confirm the risk estimate we provide. The entity has a beta of -0.28, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Swedish Orphan are expected to decrease at a much lower rate. During the bear market, Swedish Orphan is likely to outperform the market. At this point, Swedish Orphan Biovitrum has a negative expected return of -0.0701%. Please make sure to validate Swedish Orphan's mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Swedish Orphan Biovitrum performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.5 |
Modest reverse predictability
Swedish Orphan Biovitrum has modest reverse predictability. Overlapping area represents the amount of predictability between Swedish Orphan time series from 22nd of November 2024 to 7th of December 2024 and 7th of December 2024 to 22nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Swedish Orphan Biovitrum price movement. The serial correlation of -0.5 indicates that about 50.0% of current Swedish Orphan price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.5 | |
| Spearman Rank Test | -0.33 | |
| Residual Average | 0.0 | |
| Price Variance | 0.21 |
Swedish Orphan Biovitrum lagged returns against current returns
Autocorrelation, which is Swedish Orphan stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Swedish Orphan's stock expected returns. We can calculate the autocorrelation of Swedish Orphan returns to help us make a trade decision. For example, suppose you find that Swedish Orphan has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Swedish Orphan regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Swedish Orphan stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Swedish Orphan stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Swedish Orphan stock over time.
Current vs Lagged Prices |
| Timeline |
Swedish Orphan Lagged Returns
When evaluating Swedish Orphan's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Swedish Orphan stock have on its future price. Swedish Orphan autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Swedish Orphan autocorrelation shows the relationship between Swedish Orphan stock current value and its past values and can show if there is a momentum factor associated with investing in Swedish Orphan Biovitrum.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Swedish Stock
Swedish Orphan financial ratios help investors to determine whether Swedish Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Swedish with respect to the benefits of owning Swedish Orphan security.